Understanding how JMJD4 affects pancreatic cancer
Role of JMJD4 in Pancreatic Cancer
This study is looking at how a specific enzyme called JMJD4 affects the growth and spread of pancreatic cancer cells, with the hope of finding new ways to improve treatment options for patients battling this tough disease.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project ID | NIH-10952842 on NIH RePORTER |
What this research studies
This research investigates the role of the enzyme JMJD4 in pancreatic cancer, a disease known for its low survival rates. The study aims to understand how JMJD4 influences cancer cell growth and invasion, as well as its interactions with key transcription factors involved in tumor development and resistance to treatment. By examining these mechanisms, the research seeks to uncover new therapeutic targets that could lead to better treatment options for patients. The approach includes both cellular experiments and molecular analysis to elucidate JMJD4's functions in pancreatic cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pancreatic cancer.
Not a fit: Patients with other types of cancer or those without a pancreatic cancer diagnosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that improve survival rates for pancreatic cancer patients.
How similar studies have performed: Previous research has shown promising results in targeting similar molecular pathways in cancer treatment, suggesting potential for success in this approach.
Where this research is happening
Oklahoma City, United States
- University of Oklahoma Hlth Sciences Ctr — Oklahoma City, United States (Active)
Researchers
- Principal investigator: Janknecht, Ralf — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Janknecht, Ralf
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.